Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -138,885 | -74,656 | -190,098 | -59,237 | -53,020 |
| Depreciation Amortization | 9,426 | 13,919 | 14,353 | 16,195 | 18,486 |
| Accounts receivable | 8,967 | -2,991 | 1,063 | 6,729 | -7,628 |
| Accounts payable and accrued liabilities | -12,975 | 1,618 | -2,776 | 1,281 | 3,356 |
| Other Working Capital | -29,197 | -1,972 | -18,595 | -19,933 | 2,414 |
| Other Operating Activity | 19,210 | 20,795 | 106,683 | 10,904 | 20,975 |
| Operating Cash Flow | $-143,454 | $-43,287 | $-89,370 | $-44,061 | $-15,417 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 92,881 | 23,068 | -84,302 | N/A | N/A |
| PPE Investments | -8,355 | -2,831 | -3,825 | -13,264 | -12,717 |
| Net Acquisitions | 278,648 | N/A | N/A | 1,318 | 15,882 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 36,810 |
| Investing Cash Flow | $363,174 | $20,237 | $-88,127 | $-11,946 | $39,975 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 25,000 | 16,838 | N/A |
| Debt Repayment | -63,192 | -2,083 | -6,838 | -501 | N/A |
| Common Stock Issued | 2,070 | 827 | 917 | 1,494 | 22,000 |
| Common Stock Repurchased | -40,490 | -5,414 | -563 | N/A | N/A |
| Other Financing Activity | -1,004 | -139 | 212,242 | -1,872 | -1,143 |
| Financing Cash Flow | $-102,616 | $-6,809 | $230,758 | $15,959 | $20,857 |
| Exchange Rate Effect | -785 | 34 | -404 | -21 | 385 |
| Beginning Cash Position | 52,499 | 82,324 | 29,467 | 69,536 | 23,736 |
| End Cash Position | 168,818 | 52,499 | 82,324 | 29,467 | 69,536 |
| Net Cash Flow | $116,319 | $-29,825 | $52,857 | $-40,069 | $45,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | -143,454 | -43,287 | -89,370 | -44,061 | -15,417 |
| Capital Expenditure | -8,355 | -2,831 | -3,825 | -13,264 | -12,717 |
| Free Cash Flow | -151,809 | -46,118 | -93,195 | -57,325 | -28,134 |